Detalles de la búsqueda
1.
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.
Ann Hematol;
100(8): 2005-2014, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33388860
2.
A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eµ-TCL1 mice through the JNK/STAT4/p66Shc axis.
Pharmacol Res;
174: 105965, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34732370
3.
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors.
Ann Hematol;
99(7): 1525-1530, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32474619
4.
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab.
Br J Haematol;
184(2): 223-231, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30203425
5.
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy.
Hematol Oncol;
37(4): 447-455, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31385337
6.
Favorable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib.
Hematol Oncol;
38(4): 607-610, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32602167
7.
Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience.
Hematol Oncol;
37(4): 493-495, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31475736
8.
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis.
Am J Hematol;
93(7): E159-E161, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29633312
9.
Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemma.
J Chemother;
: 1-5, 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38079237
10.
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications.
Curr Oncol;
30(7): 6111-6133, 2023 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37504315
11.
Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency.
Rev Recent Clin Trials;
18(4): 300-303, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37779396
12.
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study.
Leuk Lymphoma;
64(10): 1634-1642, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37424258
13.
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR).
Cancers (Basel);
15(16)2023 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37627140
14.
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cells.
Front Pharmacol;
14: 1194712, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37305536
15.
CD26/DPP-4 in Chronic Myeloid Leukemia.
Cancers (Basel);
14(4)2022 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35205639
16.
Long-term CR Multiple Myeloma Patients Show Cured or MGUS-like Minimal Residual Disease Pattern by Next Generation Flow.
Rev Recent Clin Trials;
17(2): 92-96, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35578845
17.
Drug resistance and minimal residual disease in multiple myeloma.
Cancer Drug Resist;
5(1): 171-183, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35582527
18.
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine.
Vaccines (Basel);
10(2)2022 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35214630
19.
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients.
Front Immunol;
13: 1017863, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36248803
20.
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study).
Front Oncol;
12: 835563, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35178353